A comprehensive review on buccal patches
DOI:
https://doi.org/10.30574/gscbps.2020.13.1.0308Keywords:
Buccal mucosa, Buccal Patch/Film, Evaluation of buccal patches.Abstract
Buccal Patches are the type of drug formulation that has normally a different course of administration through the buccal mucosa for drug delivery. The product is placed between upper gingiva (gums) and cheek to treat local and systemic conditions. Buccal patch have good accessibility to the membranes that line the oral cavity. These patches tend to help drug enter directly into the systemic circulation escaping hepatic first pass metabolism. This type of drug delivery method is considered useful for elevating the bioavailability of drugs. This review is a thorough study to apprehend the procedures involved in assessment of buccal patches and the modern approach towards this type of drug delivery. This article intends to analyze the overall profile of Buccal Patches and scope of future advances.
Metrics
References
Shidhaye SS, et al. Mucoadhesive bilayered patches for administration of sumatriptan. AAPS pharm sci tech. 2009; 9(3): 1-13.
Giradkar KP, et al. Design development and in vitro evaluation of bioadhesive dosage form for buccal route. International journal of pharma research & development. 2010; 2: 1-24.
Amir H, et al. Systemic drug delivery via the buccal mucosal route, Pharmaceutical technology. 2001; 1-27.
Fatima AA, Chukwuka UK. Development and in-vitro evaluation of matrix-type transdermal patches of losartan potassium. Universal Journal of Pharmaceutical Research. 2017; 2(2): 16-20.
Steward A, et al. The Effect of Enhancers on the Buccal Absorption of Hybrid (BDBB) Alpha-Interferon.IntJ Pharm. 1994; 104: 145–149.
Al-kaf AGA, Othman AM. Pharmacosomes: an Updated review, Universal Journal of Pharmaceutical Research. 2017; 2(1): 30-33.
Mishra S. A Review articl: Recent Approaches in buccal patches, the pharma innovation. 2012;7(2):78-86.
AJ Hoogstraate, et al. Diffusion Rates and Transport Pathways of FITC-Labelled Model Compounds through Buccal Epithelium, Proc. Int. Symp. Contr. Rel. Bioact.Mater. 1993;20:234–235.
Bhartee P, Kapil Kumar. Buccal drug delivery system: a tool for the effective delivery of pharmaceuticals. Universal Journal of Pharmaceutical Research. 2017; 2(3): 19-24.
Ryan FD, Paul AM, Agnieszka AZ, David W. Design and physicochemical characterization of a bioadhesive patch for dose controlled topical delivery of imiquimod. Int J Pharm. 2006;307:3 18-25.
Shafiullah D, Pramodkumar TM, Shivakumar HG. Formulation and evaluation of chlorhexidine mucoadhesive drug delivery systems. Ind Drugs. 2006;43(2): 122-5.
Diojad RC, Manvi FV, Malleshwarrao VSN, Patel PS. Buccoadhesive drug delivery system of isosorbide dinitrate: Formulation and evaluation. Ind J Pharm Sci. 2006;68(6):744-8.
Thimmasetty J, Subramanyam CVS, Manish kumar DS, Manjunath K, Shivanand K. Design and evaluation of fexofenadine HCl buccal mucoadhesive patches. Biomed. 2007; 2(1):73-83.
Güneşm Karavana SY,Algin Yapar E.Buccal drug delivery system: an overview about dosage forms and recent studies. Universal Journal of Pharmaceutical Research. 2019; 4(6):69-74.
Mona S, Semalty A, Kumar G. Formulation and characterization of mucoadhesive buccal patches of glipizide. Ind J Pharm Sci. 2008; 70(1):43-8.
Goudanavar PS, et al. Formulation and In-vitro evaluation of mucoadhesive buccal films of Glibenclamide, Der pharmacialettre. 2010; 2 (1): 382-387.
Okorochukwu Nnamdi, Ihuaku Emmanuel C. Development and characterization of mucoadhesive patches for buccal delivery of pregabalin. Universal Journal of Pharmaceutical Research. 2017; 2(3): 6-9.
Choudhary A, et al. Formulation and characterization of carvedilol buccal mucoadhesive patches, www.ijrps.pharmascope.org. 2010; 1(4): 396-401.
Kamel AH, et al. Micromatricial metronidazole benzoate film as a local mucoadhesive delivery system for treatment of periodontal diseases, AAPS pharmscitech. 2007; 8(3): 75.
Francis DJE. Development and evaluation of matrix type transdermal patches of pioglitazone hydrochloride. Universal Journal of Pharmaceutical Research. 2016; 1(1): 17-20.
Igwe J. Chibueze, Emenike IV, Oduola AR. Formulation and evaluation of Finasteride sustained-release matrix tablets using different rate controlling polymers. Universal Journal of Pharmaceutical Research. 2016; 1(2): 15-18
Giradkar KP, et al. Design development and in vitro evaluation of bioadhesive dosage form for buccal route, International journal of pharma research & development. 2010; 2.
Agarwal P, Semimul AA. comprehensive review on sustained release matrix tablets: a promising dosage form. Universal Journal of Pharmaceutical Research. 2018; 3(6): 49-54.
Leung SS, JR Robinson, Polymer Structure Features Contributing to Mucoadhesion II, J. Contr.Rel. 1990; 12: 187–194.
Gandhi RE, Robinson JR, Bioadhesion in Drug Delivery, Indian J. Pharm. Sci. (May/June) 1988; 50: 145–152.
Peter OI, Ifeoma UC. Development and evaluation of Albendazole microcapsule for colonic drug delivery system. Universal Journal of Pharmaceutical Research. 2017; 2(2): 4-7.
Maad AH, Shayoub MEA, Elnima EI, Osman Z, Magbool FF. Formulation and evaluation of colon targeted matrix tablets containing extract of Solenostemma Argel (Hargel). Universal Journal of Pharmaceutical Research. 2019; 4(4): 33-38.
Sanzgiri YD, et al. Evaluation of Mucoadhesive Properties of Hyaluronic Acid Benzyl Esters, Int. J.Pharm. 1994; 107: 91–97.
Kumar A, Kumar K. Solid dispersion-strategy to enhance solubility and dissolution of poorly water soluble drugs. Universal Journal of Pharmaceutical Research. 2017; 2(5): 50-55.
Park K, Robinson JR, Bioadhesive Polymers as Platforms for Oral Controlled Drug Delivery, Method to Study Bioadhesion, Int. J. Pharm. 1984; 19: 107–127.
Sunday OS. Colon-targeted drug delivery systems: design, trends and approaches. Universal Journal of Pharmaceutical Research. 2017; 2(4): 46-50.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
